Evercore ISI maintains Outperform on Zimmer Biomet, cuts target to $110

0 min read     Updated on 07 Jul 2026, 01:25 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Evercore ISI Group analyst Vijay Kumar maintained an Outperform rating on Zimmer Biomet Holdings (NYSE: ZBH) but lowered the price target to $110 from $120.

powered bylight_fuzz_icon
44913310

*this image is generated using AI for illustrative purposes only.

Evercore ISI Group analyst Vijay Kumar has maintained an Outperform rating on Zimmer Biomet Holdings while adjusting the valuation outlook. The firm lowered the price target for the stock to $110, down from the previous target of $120.

The revision reflects a reassessment of the company's share price potential despite the continued positive performance expectation. Zimmer Biomet Holdings trades on the NYSE under the ticker symbol ZBH.

What specific factors led Evercore ISI to reassess Zimmer Biomet's share price potential despite maintaining an Outperform rating?

How might the lowered price target impact investor sentiment towards Zimmer Biomet in the short term?

What upcoming catalysts or events could drive Zimmer Biomet's stock closer to the new $110 price target?

like19
dislike

Zimmer Biomet to hire 500 for India tech centre in 3 years

0 min read     Updated on 02 Jul 2026, 06:39 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Medical device maker Zimmer Biomet plans to hire 500 employees over three years for its technology centre in India, aiming to strengthen its technical capabilities and regional operations.

powered bylight_fuzz_icon
44543349

*this image is generated using AI for illustrative purposes only.

Medical device maker Zimmer Biomet plans to hire 500 employees over the next three years for its technology centre in India. The strategic expansion is designed to bolster the company's technical capabilities and support its operations in the region.

Expansion Plans

The recruitment drive will focus on adding talent to the company's technology centre. This move underscores Zimmer Biomet's commitment to growing its footprint in India and leveraging local expertise.

Key Details

Aspect Details
Company Zimmer Biomet
New Hires 500
Duration 3 years
Location India (Technology Centre)

The initiative reflects the company's broader strategy to enhance its technological infrastructure and innovation capacity.

What specific roles and technical expertise will Zimmer Biomet prioritize in these new hires?

How will this expansion impact Zimmer Biomet's R&D capabilities and product innovation pipeline?

Could this move signal a broader trend of medical device companies increasing their presence in India?

like15
dislike
Must Read Next

Earnings

Corporate Actions

Stocks